News

Myriam Delvaux, global pharmaceutical marketing leader for Dow Corning Healthcare will lead the webinar and explain how silicone-based ingredients and excipients can help generate innovative product forms with

The company acquired six OTC brands from Ducere Pharma, including DOAN’S, BUFFERIN, NUPERCAINAL Ointment, CRUEX Nail Gel, COMTREX, and MYOFLEX. "These legacy products enjoy strong brand equity built

Arrivo was founded by Steve Butts, Bill Wofford, Dr. Michael Ackermann and Dr. Jed Black, and located in North Carolina’s Research Triangle Park region. Mr. Butts and Mr.

It is intended that ABLS Capital, LLC, which includes Allied Minds, Woodford Investment Management and Invesco Asset Management among its investors, will fund 80% of this phase of

These findings on BAX 930 were presented during a poster session at the 62nd annual Scientific and Standardization Committee (SSC) meeting of the International Society on Thrombosis and

About 500 patients will be enrolled in the randomized, double-blind, placebo-controlled phase 3 study, dubbed Cascade, which will assess 33A in combination with azacitidine (Vidaza) or decitabine (Dacogen)

The 15-member panel of the Endocrinologic and Metabolic Drugs Advisory Committee voted 12 to 2 (1 panelist did not vote due to travel) to approve the combination. Two

ALKS 4230, which was formerly referred to as RDB 1450, a novel selective effector cell activator protein designed to preferentially bind and signal through the intermediate affinity interleukin-2

The study, conducted in partnership with Amplion and Biomedtracker, recorded and analyzed 9,985 clinical and regulatory phase transitions, across 1,103 companies. Using clinical trial data from the past